Virtually Supervised Exercise for Kidney Transplant Candidates
Launched by STANFORD UNIVERSITY · Apr 29, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a specially designed exercise program, supervised online, can help improve the physical abilities of people waiting for a kidney transplant. Researchers want to see if this exercise approach is more effective compared to a program that focuses on health education. The study is currently recruiting participants aged 18 and older who are on the waiting list for a kidney transplant and have experienced difficulties with activities like climbing stairs or walking a half-mile.
To be eligible for this study, participants should be able to stand up from a seated position without help and have had some recent challenges with physical activities. However, individuals who have severe vision or hearing problems, certain heart conditions, or who live in nursing homes won't be able to join. Those who participate can expect to engage in exercise sessions led by a coach online, which could be a great way to improve their strength and mobility while they wait for their transplant.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 18 years old
- • Listed for kidney transplant
- * Positive answers (e.g. yes) to one of the following:
- • current difficulty with climbing up 10 stairs,
- • has changed in the past year how they climb 10 stairs
- • current difficulty with walking a 0.5 mile (5-6 blocks)
- • has changed in past year in how they walk 0.5 mile (5-6 blocks)
- • documented performance of 430 meters or less on the six minute walk test in the past 12 months
- • documented performance of 9 points or less on the Short Physical Performance Battery in the past 24 months
- • documented performance of less than 3 points or less on the five times sit to stand test in the past 24 months
- • Demonstrated ability to stand up independently from a seated position and then sit back down without using their arms or an assistive device in the past 24 months
- Exclusion Criteria:
- • Does not speak English or Spanish
- • Nursing home resident
- • Severe low vision (≥20/200 with corrective lens)
- • Severe hearing loss even with use of amplification preventing communication
- • Unstable angina or uncontrolled arrhythmia
- • Supplemental oxygen therapy
- • Myocardial infarction, major heart surgery, stroke, venous thromboembolism, hip fracture, hip or knee replacement in past six months (temporary exclusion)
- • ≥ 3 errors on the Six Item Screener
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials